Form 13-F position report

IMMUNIC INC COM (DE)

Reported by MILLENNIUM MANAGEMENT LLC

IMUX CUSIP 4525EP101 Manager CIK 0001273087

Reported 524,563 shares, down 46,138 (8.1%) from the prior quarter.

Reported value 8.5%; share count -8.1% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2022
Shares 524,563 Quarter-end amount reported
Reported value $5,928,000 Fair value at quarter end
Consecutive quarters held 12 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 4382000
2021-12-31 5462000
2022-03-31 5928000
2022-06-30 3953000
2022-09-30 3819000
2022-12-31 1024000
2023-03-31 1884000
2023-06-30 2373950
2023-09-30 156136
2023-12-31 0
2024-03-31 158471
2024-06-30 32938
2024-09-30 164731
2024-12-31 579683
2025-03-31 109998
2025-06-30 71919
2025-09-30 467662
2025-12-31 1824880
2026-03-31 4195713
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for IMMUNIC INC COM (DE) held by MILLENNIUM MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -3,779,922 (-100.0%) 0 $0 2026-08-14
Q1 2026 Added 3,779,922 +360,623 (10.5%) < 0.01% $4,195,713 2026-05-15
Q4 2025 Added 3,419,299 +2,888,829 (544.6%) < 0.01% $1,824,880 2026-02-17
Q3 2025 Added 530,470 +427,361 (414.5%) < 0.01% $467,662 2025-11-14
Q2 2025 Added 103,109 +2,193 (2.2%) < 0.01% $71,919 2025-08-14
Q1 2025 Reduced 100,916 -478,767 (-82.6%) < 0.01% $109,998 2025-05-15
Q4 2024 Added 579,683 +479,846 (480.6%) < 0.01% $579,683 2025-02-14
Q3 2024 Added 99,837 +70,163 (236.4%) < 0.01% $164,731 2024-11-14
Q2 2024 Reduced 29,674 -90,380 (-75.3%) < 0.01% $32,938 2024-08-14
Q1 2024 New 120,054 +120,054 (0.0%) < 0.01% $158,471 2024-05-15
Q4 2023 Reduced 0 -106,215 (-100.0%) 0 $0 2024-02-14
Q3 2023 Reduced 106,215 -839,582 (-88.8%) < 0.01% $156,136 2023-11-14
Q2 2023 Reduced 945,797 -318,826 (-25.2%) < 0.01% $2,373,950 2023-08-14
Q1 2023 Added 1,264,623 +533,079 (72.9%) < 0.01% $1,884,000 2023-05-15
Q4 2022 Reduced 731,544 -476,950 (-39.5%) < 0.01% $1,024,000 2023-02-14
Q3 2022 Added 1,208,494 +69,340 (6.1%) < 0.01% $3,819,000 2022-11-14
Q2 2022 Added 1,139,154 +614,591 (117.2%) < 0.01% $3,953,000 2022-08-15
Q1 2022 Reduced 524,563 -46,138 (-8.1%) < 0.01% $5,928,000 2022-05-16
Q4 2021 Added 570,701 +75,530 (15.3%) < 0.01% $5,462,000 2022-02-14
Q3 2021 Added 495,171 +255,615 (106.7%) < 0.01% $4,382,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

87 managers reported IMMUNIC INC COM (DE) for Q1 2022.

Managers reporting IMMUNIC INC COM (DE) in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RTW INVESTMENTS LP Added 2,705,513 +990,043 0.63% $30,572,000 7 qtrs
Omega Fund Management LLC Unchanged 1,788,160 0 4.14% $20,206,000 12 qtrs
BlackRock Inc Added 1,314,484 +11,708 < 0.01% $14,853,000 12 qtrs
COWEN AND COMPANY LLC Added 1,257,146 +1,001,291 1.37% $14,206,000 2 qtrs
Parkman Healthcare Partners LLC Added 1,089,251 +115,068 3.6% $12,309,000 8 qtrs
VANGUARD GROUP INC Added 956,697 +54,867 < 0.01% $10,811,000 12 qtrs
COMMODORE CAPITAL LP New 893,013 +893,013 2.25% $10,091,000 1 qtr
Point72 Asset Management L P Unchanged 725,000 0 0.03% $8,193,000 8 qtrs
Artal Group S A Unchanged 700,000 0 0.33% $7,910,000 10 qtrs
PURA VIDA INVESTMENTS LLC New 683,287 +683,287 0.25% $7,721,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
524,563
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.